Companies Partner on Tech for Finding Best Time to Take Medication

Two European pharma companies have teamed up to create a technology platform that will help people with Parkinson’s disease find the best time to take their medication and make personalized adjustments to their treatment schedules. Gerresheimer AG is partnering with Finnish MedTech start-up Adamant Health Oy on new…

DBS in Early Parkinson’s Found to Lower Medication Use, Costs

Deep brain stimulation (DBS) in adults with early Parkinson’s reduces disease-specific medication use and provides significant cost savings, for up to 15 years, relative to standard care, a study shows. While these savings — just over $100,000 over 15 years — did not outweigh the costs of the surgical…

Earlier Onset, Cognitive Impairment and Higher Medication Use Linked to Increased Parkinson’s-related Mortality

Earlier onset of disease, early impairment of memory and thinking, and higher daily use of antiparkinson medication, are associated with increased risk of death related to Parkinson’s disease (PD), according to a study that followed newly diagnosed patients for more than 10 years. Conversely, being male, the severity of…